Mckinley Capital Management LLC Merck & Co., Inc. Transaction History

Mckinley Capital Management LLC

$558 Million
Q2 2024

A detailed history of Mckinley Capital Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mckinley Capital Management LLC holds 41,321 shares of MRK stock, worth $4.1 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares

41,321

Previous 32,858 25.76%

Holding current value

$4.1 Million

Previous $4.34 Million 17.99%

% of portfolio

0.92%

Previous 0.54%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $1.05 Million - $1.13 Million	8,463 Added 25.76%	41,321 $5.12 Million
Q1 2024 May 01, 2024	SELL	$113.24 - $131.95 $244,371 - $284,748	-2,158 Reduced 6.16%	32,858 $4.34 Million
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $3.02 Million - $3.28 Million	-30,104 Reduced 46.23%	35,016 $3.82 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $2.27 Million - $2.52 Million	-22,072 Reduced 25.31%	65,120 $6.7 Million
Q2 2023 Aug 09, 2023	SELL	$108.61 - $118.38 $950,771 - $1.04 Million	-8,754 Reduced 9.12%	87,192 $10.1 Million
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $119,822 - $133,697	-1,164 Reduced 1.2%	95,946 $10.2 Million
Q4 2022 Jan 18, 2023	SELL	$87.44 - $112.11 $62,344 - $79,934	-713 Reduced 0.73%	97,110 $0
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $6.02 Million - $6.76 Million	71,167 Added 266.98%	97,823 $8.42 Million
Q2 2022 Aug 05, 2022	BUY	$83.49 - $94.64 $984,013 - $1.12 Million	11,786 Added 79.26%	26,656 $2.43 Million
Q1 2022 Apr 29, 2022	BUY	$73.51 - $82.4 $18,303 - $20,517	249 Added 1.7%	14,870 $1.22 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $9,757 - $12,222	135 Added 0.93%	14,621 $1.12 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $51,179 - $56,284	-714 Reduced 4.7%	14,486 $1.09 Million
Q2 2021 Aug 03, 2021	BUY	$70.31 - $77.77 $421 - $466	6 Added 0.04%	15,200 $1.18 Million
Q1 2021 Apr 21, 2021	SELL	$68.86 - $81.11 $8.69 Million - $10.2 Million	-126,128 Reduced 89.25%	15,194 $1.17 Million
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $5.93 Million - $6.59 Million	-82,684 Reduced 36.91%	141,322 $11.6 Million
Q3 2020 Nov 02, 2020	SELL	$73.18 - $82.95 $7.18 Million - $8.14 Million	-98,098 Reduced 30.46%	224,006 $18.6 Million
Q2 2020 Jul 27, 2020	SELL	$70.42 - $80.13 $3.26 Million - $3.71 Million	-46,272 Reduced 12.56%	322,104 $24.9 Million
Q1 2020 May 05, 2020	SELL	$63.36 - $87.82 $215,804 - $299,114	-3,406 Reduced 0.92%	368,376 $28.3 Million
Q4 2019 Jan 23, 2020	BUY	$77.58 - $87.54 $2.71 Million - $3.06 Million	34,920 Added 10.37%	371,782 $33.8 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $7.81 Million - $8.52 Million	102,683 Added 43.85%	336,862 $28.4 Million
Q2 2019 Aug 07, 2019	SELL	$69.84 - $81.59 $450,956 - $526,826	-6,457 Reduced 2.68%	234,179 $19.6 Million
Q1 2019 May 02, 2019	BUY	$69.58 - $79.36 $607,711 - $693,130	8,734 Added 3.77%	240,636 $20 Million
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $14.1 Million - $16.4 Million	216,389 Added 1394.89%	231,902 $17.7 Million
Q3 2018 Nov 08, 2018	BUY	$57.69 - $67.84 $3,807 - $4,477	66 Added 0.43%	15,513 $1.1 Million
Q2 2018 Jul 13, 2018	BUY	$50.83 - $59.72 $41,426 - $48,671	815 Added 5.57%	15,447 $938,000
Q1 2018 May 04, 2018	SELL	$50.96 - $59.23 $95,651 - $111,174	-1,877 Reduced 11.37%	14,632 $797,000
Q4 2017 Feb 08, 2018	SELL	$51.62 - $61.64 $30,868 - $36,860	-598 Reduced 3.5%	16,509 $929,000
Q3 2017 Nov 13, 2017	SELL	$58.67 - $63.13 $124,497 - $133,961	-2,122 Reduced 11.04%	17,107 $1.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	19,229	19,229 $1.23 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Mckinley Capital Management LLC with notifications on news.

Account

Mckinley Capital Management LLC Merck & Co., Inc. Transaction History